Ted Monohon - 06 Mar 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Chief Accounting Officer & VP
Signature
/s/ Ted Monohon
Issuer symbol
QNCX
Transactions as of
06 Mar 2023
Net transactions value
-$1,834
Form type
4
Filing time
06 Mar 2023, 17:55:56 UTC
Previous filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Sale $1,834 -1,871 -6.4% $0.9800 27,440 06 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022.